Paper14484792
The effect of a serotonin antagonist (UML 491) in carcinoid disease.
PEART WS and 1 other. Lancet, 1961. Cited by 51 papers, by iCite.
Cite this record
ConductScience Library. The effect of a serotonin antagonist (UML 491) in carcinoid disease. Papers, record 14484792. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/14484792
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoid Tumor | Major topic |
| Malignant Carcinoid Syndrome | Major topic |
| Methysergide | Major topic |
| Serotonin Antagonists | Major topic |
| Lysergic Acid Diethylamide |
Source PubMed
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 51 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 18668794 | Motor responses of human gastrointestinal tract to 5-hydroxytryptamine in vivo and in vitro. | Gut | 1966 | https://conductscience.org/library/papers/18668794 | PubMed |
| 14479461 | Effect of methyldopa in carcinoid disease. | Br Med J | 1962 | https://conductscience.org/library/papers/14479461 | PubMed |
| 8100206 | Effects of serotonin on rat ileocolonic transit and fluid transfer in vivo: possible mechanisms of action. | Gut | 1993 | https://conductscience.org/library/papers/8100206 | PubMed |
| 6181801 | Use of arterial devascularization and cytotoxic drugs in 30 patients with the carcinoid syndrome. | Br J Cancer | 1982 | https://conductscience.org/library/papers/6181801 | PubMed |
| 6050497 | Antagonism by methysergide of vascular effects of 5-hydroxytryptamine in man. | Br J Pharmacol Chemother | 1967 | https://conductscience.org/library/papers/6050497 | PubMed |
| 6020139 | The effect of 5-hydroxytryptamine on the human colon in vivo and in vitro. | Proc R Soc Med | 1967 | https://conductscience.org/library/papers/6020139 | PubMed |
| 5497834 | The release of biologically active substances from isolated lungs by 5-hydroxytryptamine and tryptamine. | Br J Pharmacol | 1970 | https://conductscience.org/library/papers/5497834 | PubMed |
| 5031235 | Forgotten bradykinin? | Br Med J | 1972 | https://conductscience.org/library/papers/5031235 | PubMed |
| 4333528 | Diarrhoea: mechanisms and treatment. | Gut | 1971 | https://conductscience.org/library/papers/4333528 | PubMed |
| 2285651 | Carcinoid syndrome and serotonin: therapeutic effects of ketanserin. | Cardiovasc Drugs Ther | 1990 | https://conductscience.org/library/papers/2285651 | PubMed |
| 2285645 | Serotonin and vascular disease: a survey. | Cardiovasc Drugs Ther | 1990 | https://conductscience.org/library/papers/2285645 | PubMed |
| 656815 | Surgical approaches and drug treatment in the carcinoid syndrome. | Br Med J | 1978 | https://conductscience.org/library/papers/656815 | PubMed |
| 390899 | Prostaglandins and serotonin: nonpeptide diarrheogenic hormones. | World J Surg | 1979 | https://conductscience.org/library/papers/390899 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/14484792
GET https://conductscience.org/api/papers/v1/14484792/authors